Drug Pricing HIPAA Pharmaceutical Companies 
Pharma Marketing Network
JULY 26, 2025
For starters, trust in pharmaceutical companies remains fragile. Scandals, misinformation, and aggressive drug pricing continue to erode confidence, even when products like Ozempic and DUPIXENT bring groundbreaking benefits. Even large pharmaceutical companies sometimes struggle to extract value from their tech stack.
Pharma Marketing Network
APRIL 17, 2025
For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.
Expert insights. Personalized for you.
Let's personalize your content